STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

HARP HARPOON THERAPEUTICS INCORPORATED StockScouter® Report

1

StockScouter® Score

HARPOON THERAPEUTICS INCORPORATED, a small cap growth company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive

 

Concerns

  • The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
  • The multi-period measure of relative price change and consistency is below average. Negative/Neutral
  • Shares are being sold by financial institutions. Slightly negative for a small company like HARP

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 100% done.
Progress: 20% done.
Low
High

Core Model Grades

C
C
F
D

Previous Ratings

3
3
5